BrainsWay Ltd.

BWAY

IL0011007189

Advanced Medical Equipment & Technology

Delayed TEL AVIV STOCK EXCHANGE Other stock markets 02:15:13 26/05/2024 pm IST			5-day change	1st Jan Change
999.1 ^ILa	-0.78%		+0.39%	-13.05%

09/05	Oppenheimer Adjusts Brainsway Price Target to $11 From $10, Maintains Outperform Rating	MT
09/05	HC Wainwright Adjusts Price Target on Brainsway to $15 From $13, Keeps Buy Rating	MT

Brainsway Announces Resignation of Guy Ezekiel as CEO

May 31, 2016 at 04:25 pm IST

Brainsway's announced that CEO Guy Ezekiel was stepping down after less than a year in the role. Ezekiel's departure was likely spurred by a number of reasons.

Latest news about BrainsWay Ltd.

Oppenheimer Adjusts Brainsway Price Target to $11 From $10, Maintains Outperform Rating	09/05	MT
HC Wainwright Adjusts Price Target on Brainsway to $15 From $13, Keeps Buy Rating	09/05	MT
Transcript : BrainsWay Ltd., Q1 2024 Earnings Call, May 08, 2024	08/05
BrainsWay Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	08/05	CI
BrainsWay Ltd. Reiterates Revenue Guidance for the Year 2024	08/05	CI
Brainsway Expands Deep Tms Access in Israel Following Significant Increase in Reimbursement Rates	17/04	CI
BrainsWay Ltd. Announces Publish Review Results Highlighting Potential of Deep Transcranial Magnetic Stimulation (Deep TMS?) as a Novel Therapeutic Approach for Parkinson's Disease	04/04	CI
Brainsway Announces Positive Results in Late-Life Depression Post-Marketing Analysis	28/03	CI
BrainsWay Ltd. Broadens Partnership with Katie?s Way Plus Through Order of an Additional 18 Deep TMS? Systems	18/03	CI
Transcript : BrainsWay Ltd., Q4 2023 Earnings Call, Mar 06, 2024	06/03
BrainsWay Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	06/03	CI
BrainsWay Ltd. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	06/03	CI
Brainsway Ltd. Provides Earnings Guidance for Full Year 2024	06/03	CI
BrainsWay Ltd. Announces New Rotational Field Technology in Two New Feasibility Studies	10/01	CI
Brainsway Expands Deep Transcranial Magnetic Stimulation Technology in South Korea	07/12	MT
BrainsWay Ltd. Announces Continued Expansion of Deep TMS in South Korea	07/12	CI
Brainsway Says Blue Cross Blue Shield of Louisiana Expands Access to Mental-Health Technology	20/11	MT
Oppenheimer Adjusts Price Target on Brainsway to $6 From $5.50, Maintains Outperform Rating	16/11	MT
Raymond James Downgrades Brainsway to Market Perform From Outperform	16/11	MT
Transcript : BrainsWay Ltd., Q3 2023 Earnings Call, Nov 15, 2023	15/11
Earnings Flash (BWAY) BRAINSWAY Reports Q3 Revenue $8.3M	15/11	MT
BrainsWay Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	15/11	CI
BrainsWay Ltd. Announces Publishes the First Coverage Recommendations for Smoking Addiction Treatment Using TMS	02/11	CI
BrainsWay Announces Publication of Study Data on Accelerated Deep Transcranial Magnetic Stimulation (Deep TMS) for Depression	16/23/16	CI
Brainsway Receives 10 Orders for Deep Transcranial Magnetic Stimulation	20/23/20	MT

Brainsway Ltd is an Israel-based company engaged in the development and marketing of medical devices for the treatment of various neurological and psychopathological disorders. The Company primarily offers Transcranial Magnetic Stimulation (TMS) system, a medical device that enables direct non-invasive activation of deep brain structures. Its TMS system uses magnetic pulses to stimulate neurons and consequently modulates the physiological activity of the brain. TMS system is used in various clinical applications including: major depressive disorders, obsessive-compulsive disorder, smoking addiction and others various psychiatric, neurological, and addiction disorders.

Sector

Advanced Medical Equipment & Technology

Calendar

07/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Quarterly revenue - Rate of surprise

Company calendar

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
BRAINSWAY LTD.	-13.05%	91.53M
THERMO FISHER SCIENTIFIC	+10.03%	223B
DANAHER CORPORATION	+13.59%	195B
INTUITIVE SURGICAL, INC.	+20.01%	144B
BOSTON SCIENTIFIC CORPORATION	+30.83%	111B
SIEMENS HEALTHINEERS AG	+2.05%	65.01B
EDWARDS LIFESCIENCES CORPORATION	+15.38%	53.02B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	+3.96%	50.45B
AGILENT TECHNOLOGIES, INC.	+8.37%	44.15B
GE HEALTHCARE TECHNOLOGIES INC.	+3.27%	36.45B

Other Advanced Medical Equipment & Technology

BrainsWay Ltd.

Equities

BWAY

IL0011007189

Advanced Medical Equipment & Technology

Brainsway Announces Resignation of Guy Ezekiel as CEO

Latest news about BrainsWay Ltd.

Chart BrainsWay Ltd.

Company Profile

Income Statement Evolution

Quarterly revenue - Rate of surprise

Sector Other Advanced Medical Equipment & Technology